Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Current Leases: 2022-2024

Historic Current Leases for Dianthus Therapeutics (DNTH) over the last 3 years, with Dec 2024 value amounting to $320,000.

  • Dianthus Therapeutics' Current Leases fell 30.23% to $217,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $217,000, marking a year-over-year decrease of 30.23%. This contributed to the annual value of $320,000 for FY2024, which is 23.26% down from last year.
  • Dianthus Therapeutics' Current Leases amounted to $320,000 in FY2024, which was down 23.26% from $417,000 recorded in FY2023.
  • Over the past 5 years, Dianthus Therapeutics' Current Leases peaked at $417,000 during FY2023, and registered a low of $320,000 during FY2024.
  • For the 3-year period, Dianthus Therapeutics' Current Leases averaged around $362,333, with its median value being $350,000 (2022).
  • Its Current Leases has fluctuated over the past 5 years, first increased by 19.14% in 2023, then declined by 23.26% in 2024.
  • Over the past 3 years, Dianthus Therapeutics' Current Leases (Yearly) stood at $350,000 in 2022, then rose by 19.14% to $417,000 in 2023, then fell by 23.26% to $320,000 in 2024.